Lantheus Alpha Therapy, LLC
Known title: 10% OwnerCIK: 0002010224
Lantheus Alpha Therapy, LLC's purchase track record
Lantheus Alpha Therapy, LLC has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/6/2024 | CATX | $57.41M | +38.2% | +46.9% | +8.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CATX | ▼ Sell | Open Market | 167,149 | $526K | 9/4/2026 | View on chart |
| CATX | ▼ Sell | Open Market | 80,783 | $251K | 9/3/2026 | View on chart |
| CATX | ▼ Sell | Open Market | 42,129 | $131K | 9/2/2026 | View on chart |
| CATX | ▼ Sell | Open Market | 35,769 | $112K | 9/1/2026 | View on chart |
| CATX | ▼ Sell | Open Market | 78,145 | $246K | 8/31/2026 | View on chart |
| CATX | ▲ Buy | Open Market | 60,431,039 | $57.4M | 3/6/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
CATX included in pre-market movers list
Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.
CATX included in pre-market movers list. Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.